Overview
Supraglottic stenosis refers to the narrowing of the supraglottic region of the upper airway, typically affecting structures above the true vocal cords such as the epiglottis and arytenoid cartilages. This condition can significantly impair breathing, swallowing, and voice quality, often necessitating surgical intervention or tracheostomy in severe cases. It predominantly affects patients with a history of laryngectomy, radiation therapy, trauma, or caustic ingestion. Given its potential for life-threatening airway obstruction, early recognition and appropriate management are crucial in day-to-day clinical practice to prevent complications and ensure optimal patient outcomes 12.Pathophysiology
Supraglottic stenosis develops through a complex interplay of mechanical and inflammatory processes. Mechanical factors often include scarring from previous surgeries, radiation-induced tissue damage, or direct trauma to the supraglottic structures. These insults trigger a cascade of cellular responses, including fibroblast proliferation and excessive collagen deposition, leading to fibrotic changes and stenosis formation. Inflammatory mediators such as cytokines and growth factors (e.g., basic fibroblast growth factor (bFGF) and transforming growth factor beta1 (TGF-beta1)) play pivotal roles in amplifying the fibrotic process, further contributing to the narrowing of the airway 15. Morphological features like epiglottic fixation and arytenoid cartilage involvement are associated with more severe functional impairments, underscoring the importance of both structural and functional assessments in understanding disease progression 1.Epidemiology
The incidence of supraglottic stenosis is relatively rare but increases in specific populations, particularly those who have undergone laryngectomy or received radiation therapy for head and neck cancers. Age and sex distributions vary, with older adults more commonly affected due to higher prevalence of risk factors like cancer treatment. Geographic and environmental factors may also play a role, though specific prevalence data are limited. Trends suggest an increasing recognition of this condition as diagnostic imaging techniques improve and patient survival rates rise post-radiation and surgical interventions 12.Clinical Presentation
Patients with supraglottic stenosis typically present with symptoms of airway obstruction, including dyspnea, stridor, and in severe cases, cyanosis and respiratory distress. Dysphagia and changes in voice quality, such as hoarseness or aphonia, are also common. Atypical presentations may include recurrent respiratory infections due to compromised airway clearance. Red-flag features include acute onset of severe dyspnea, hypercarbia, and signs of impending airway collapse, necessitating urgent evaluation and intervention 2.Diagnosis
The diagnostic approach for supraglottic stenosis involves a combination of clinical assessment, imaging, and direct visualization techniques. Key diagnostic criteria include:Laryngoscopy: Essential for direct visualization of the supraglottic structures. Identification of stenotic areas, morphological features (e.g., epiglottic fixation, arytenoid cartilage involvement), and functional status are critical.
Imaging: Three-dimensional computed tomography (CT) reconstructions can provide detailed anatomical information, especially useful in postlaryngectomy patients to assess the internal shape and extent of stenosis 2.
Novel Grading System: Developed based on morphology and functional status, this system categorizes stenosis into grades that enhance communication and patient management:
- Grade 0: No stenosis, normal function.
- Grade 1: Mild stenosis, minimal functional impairment.
- Grade 2: Moderate stenosis, significant functional impairment (e.g., requiring G-tube).
- Grade 3: Severe stenosis, severe functional impairment (e.g., necessitating tracheostomy).
- Inter-rater reliability: Substantial to almost perfect (Kw ≥ 0.7) 1.Differential Diagnosis:
Asthma: Often misdiagnosed due to similar respiratory symptoms; ruled out by laryngoscopy and imaging.
Postoperative Granulation Tissue: Distinguished by clinical history and endoscopic findings showing granulation tissue rather than fixed stenosis.
Benign Vocal Fold Lesions: Differentiates based on location and response to voice therapy versus surgical intervention 2.Management
Initial Management
Airway Stabilization: Immediate intervention may include tracheostomy for severe cases to ensure airway patency.
Medical Management:
- Inhaled Steroids: Postoperative use of inhaled corticosteroids (ICS) can reduce granulation tissue formation post-glottic surgery, potentially minimizing the need for further surgical interventions. Dose typically ranges from 800 mcg to 1600 mcg daily, depending on the severity and duration of treatment 3.
- Anti-inflammatory Agents: Consideration of systemic anti-inflammatory medications if granulation tissue is a concern, though specific dosing varies based on patient condition.Surgical Interventions
Microlaryngeal Surgery: Techniques such as excision of stenotic lesions using CO2 laser, often with application of antimitotic agents like mitomycin C or chitosan to prevent recurrence.
- Mitomycin C: Applied topically for 5 minutes post-surgery, with dosing typically at 0.2 mg/mL 5.
- Chitosan: Alternative to mitomycin C, showing efficacy in reducing fibrosis in experimental models 5.
Tracheotomy: Indicated for temporary airway management in severe cases, with eventual decannulation planned post-recovery or definitive surgical correction.Refractory Cases
Multidisciplinary Approach: Collaboration with otolaryngologists, pulmonologists, and speech therapists for comprehensive care.
Advanced Surgical Techniques: Consideration of combined procedures like transverse cordotomy and anteromedial arytenoidectomy (TCAMA) for glottic stenosis, though these are more relevant to glottic rather than supraglottic stenosis 4.Contraindications:
Severe comorbidities precluding surgery.
Uncontrolled systemic infections.Complications
Acute Complications: Respiratory failure, airway obstruction requiring emergency intervention.
Long-term Complications: Persistent dysphagia, chronic aspiration, and recurrent stenosis necessitating repeated surgical interventions.
Management Triggers: Regular follow-up laryngoscopies and imaging to monitor for recurrence or complications, prompt referral to specialists if signs of worsening symptoms or new onset of complications arise 12.Prognosis & Follow-up
The prognosis for supraglottic stenosis varies based on the severity and underlying etiology. Early intervention and appropriate management generally yield favorable outcomes, with decannulation rates improving over time. Prognostic indicators include the initial severity grade, response to initial treatment, and absence of recurrent etiological factors. Recommended follow-up intervals typically include:
Initial Postoperative: Weekly laryngoscopy and clinical assessment for the first month.
Subsequent: Every 3-6 months for the first year, then annually to monitor for recurrence and functional status 12.Special Populations
Postlaryngectomy Patients: Higher risk due to altered anatomy; meticulous imaging and surgical planning are essential.
Radiation Therapy Recipients: Increased risk of fibrotic changes; close monitoring and prophylactic measures may be necessary.
Elderly Patients: Consider comorbidities and overall health status when planning interventions; multidisciplinary care is crucial 2.Key Recommendations
Utilize a Novel Grading System for supraglottic stenosis based on morphology and functional status to standardize communication and patient management (Evidence: Strong 1).
Perform Laryngoscopy as the primary diagnostic tool to assess morphological features and functional impairment (Evidence: Strong 1).
Consider Inhaled Corticosteroids postoperatively in glottic surgeries to reduce granulation tissue formation (Evidence: Moderate 3).
Apply Mitomycin C or Chitosan topically post-surgery to prevent recurrence of stenosis (Evidence: Moderate 5).
Ensure Airway Stabilization with tracheostomy if severe stenosis threatens respiratory function (Evidence: Expert opinion).
Monitor Patients Regularly with laryngoscopy and clinical assessments, especially in the first year post-treatment (Evidence: Moderate 1).
Collaborate Multidisciplinarily involving otolaryngologists, pulmonologists, and speech therapists for comprehensive care (Evidence: Expert opinion).
Evaluate for Recurrent Etiological Factors in follow-up to prevent recurrence (Evidence: Moderate 2).
Adjust Management Based on Severity Grades, escalating interventions as needed from medical to surgical approaches (Evidence: Strong 1).
Consider Patient-Specific Factors such as age, comorbidities, and prior treatments when planning interventions (Evidence: Expert opinion).References
1 Aziz S, O'Dell K, Johns M, Schindler J, Merati A, Alanazi A et al.. A Novel Grading System for Supraglottic Stenosis Based on Morphology and Functional Status. The Laryngoscope 2023. link
2 Chon J, Hong S, Lee S, Shin M, Cha S, Lee J. Postlaryngectomy supraglottic stenosis revealed by three-dimensional computed tomography reconstruction: A case report. Medicine 2022. link
3 Hollis AN, Ghodke A, Farquhar D, Buckmire RA, Shah RN. Postoperative Inhaled Steroids Following Glottic Airway Surgery Reduces Granulation Tissue Formation. The Annals of otology, rhinology, and laryngology 2022. link
4 Ghodke A, Tracy LF, Hollis A, Adams K, Shah RN, Buckmire RA. Combined Transverse Cordotomy- Anteromedial Arytenoidectomy for Isolated Glottic Stenosis. The Laryngoscope 2021. link
5 Fang R, Sun J, Wan G, Sun D. Comparison between mitomycin C and chitosan for prevention of anterior glottic steno after CO2 laser cordectomy in dogs. The Laryngoscope 2007. link